Gene expression of neuregulin-1 isoforms in different brain regions of elderly schizophrenia patients

One important risk gene in schizophrenia is neuregulin-1 (NRG1), which is expressed in different isoforms in the brain. To determine if alterations of NRG1 are present in schizophrenia, we measured gene expression of NRG1 and its main isoforms as well as the impact of genetic variation of NRG1 in an exploratory study examining three brain regions instead of only one as published so far. In all, we examined post-mortem samples from 11 schizophrenia patients and eight normal subjects. We investigated gene expression of total NRG1 and isoforms I, II and III by real-time PCR in the prefrontal cortex (Brodmann areas 9 and 10) and right hippocampal tissue. For the genetic study, we genotyped the NRG1 polymorphism SNP8NRG221533, which is within the core haplotype of the original publication. Compared to controls, gene expression of the NRG1 isoform I was decreased and isoform II increased in the prefrontal cortex (BA10) of schizophrenia patients. There were no statistically significant differences between individuals carrying at least one C allele of SNP8NRG221533 compared to individuals homozygous for the T allele. The decreased expression of NRG1 isoform I and overexpression of isoform II may be related to deficits in receptor function as well as abnormal migration and myelination. However, our study sample was small and results of this exploratory study should be verified in a larger sample.

[1]  Peter Falkai,et al.  Immunohistochemical Evidence for Impaired Neuregulin‐1 Signaling in the Prefrontal Cortex in Schizophrenia and in Unipolar Depression , 2007, Annals of the New York Academy of Sciences.

[2]  J. Kleinman,et al.  Critical Factors in Gene Expression in Postmortem Human Brain: Focus on Studies in Schizophrenia , 2006, Biological Psychiatry.

[3]  H. Braak,et al.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry , 2006, Acta Neuropathologica.

[4]  M. Munafo,et al.  Association of the NRG1 gene and schizophrenia: a meta-analysis , 2006, Molecular Psychiatry.

[5]  Brien Riley,et al.  Molecular genetic studies of schizophrenia , 2006, European Journal of Human Genetics.

[6]  Paul J. Harrison,et al.  Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[7]  P. Sklar,et al.  Schizophrenia: do the genetics and neurobiology of neuregulin provide a pathogenesis model? , 2006, Harvard review of psychiatry.

[8]  H. Möller,et al.  World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Long-term treatment of schizophrenia , 2006 .

[9]  H. Möller,et al.  World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Long-term treatment of schizophrenia , 2006, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[10]  R. Siegel,et al.  Neuregulin induces GABAA receptor β2 subunit expression in cultured rat cerebellar granule neurons by activating multiple signaling pathways , 2004, Journal of neurochemistry.

[11]  H. Stefánsson,et al.  Identification of a novel neuregulin 1 at-risk haplotype in Han schizophrenia Chinese patients, but no association with the Icelandic/Scottish risk haplotype , 2004, Molecular Psychiatry.

[12]  J. Buxbaum,et al.  Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia , 2004, Nature Neuroscience.

[13]  R Hashimoto,et al.  Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia , 2004, Molecular Psychiatry.

[14]  Leena Peltonen,et al.  Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. , 2003, American journal of human genetics.

[15]  Patrick R Hof,et al.  Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia , 2003, Biological Psychiatry.

[16]  Philip D. Harvey,et al.  White matter changes in schizophrenia: evidence for myelin-related dysfunction. , 2003, Archives of general psychiatry.

[17]  M C O'Donovan,et al.  Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia , 2003, Molecular Psychiatry.

[18]  Douglas L Falls,et al.  Neuregulins: functions, forms, and signaling strategies. , 2003, Experimental cell research.

[19]  H. Stefánsson,et al.  Neuregulin 1 and susceptibility to schizophrenia. , 2002, American journal of human genetics.

[20]  Akira Sawa,et al.  Schizophrenia: Diverse Approaches to a Complex Disease , 2002, Science.

[21]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[22]  G. Fischbach,et al.  Neuregulins Increase α7 Nicotinic Acetylcholine Receptors and Enhance Excitatory Synaptic Transmission in GABAergic Interneurons of the Hippocampus , 2001, The Journal of Neuroscience.

[23]  G. Fischbach,et al.  Neuregulin and ErbB receptor signaling pathways in the nervous system , 2001, Current Opinion in Neurobiology.

[24]  C. Birchmeier,et al.  Neuregulin, a factor with many functions in the life of a Schwann cell , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[25]  T. Hashikawa,et al.  Roles of neuregulin in synaptogenesis between mossy fibers and cerebellar granule cells , 2000, Journal of neuroscience research.

[26]  R. Straub,et al.  Clinical features of schizophrenia and linkage to chromosomes 5q, 6p, 8p, and 10p in the Irish Study of High-Density Schizophrenia Families. , 2000, The American journal of psychiatry.

[27]  H. Yeh,et al.  Neuregulin Induces GABAA Receptor Subunit Expression and Neurite Outgrowth in Cerebellar Granule Cells , 1999, The Journal of Neuroscience.

[28]  B. Bogerts.  The neuropathology of schizophrenic diseases: historical aspects and present knowledge , 1999, European Archives of Psychiatry and Clinical Neuroscience.

[29]  C. Stefanis,et al.  Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21 , 1998, Nature Genetics.

[30]  O. Shirakawa,et al.  Isotype-Specific G Protein Abnormalities in the Left Superior Temporal Cortex and Limbic Structures of Patients with Chronic Schizophrenia , 1998, Biological Psychiatry.

[31]  Michael Sasner,et al.  Neuregulin-β induces expression of an NMDA-receptor subunit , 1997, Nature.

[32]  P. Rakic,et al.  Role of GGF/neuregulin signaling in interactions between migrating neurons and radial glia in the developing cerebral cortex. , 1997, Development.

[33]  C. Birchmeier,et al.  Isoform-specific expression and function of neuregulin. , 1997, Development.

[34]  R. Straub,et al.  Evidence for a schizophrenia vulnerability locus on chromosome 8p in the Irish Study of High-Density Schizophrenia Families. , 1996, The American journal of psychiatry.

[35]  P. Maycox,et al.  Cell death in the Schwann cell lineage and its regulation by neuregulin. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Daniel R Weinberger,et al.  On the Plausibility of “The Neurodevelopmental Hypothesis” of Schizophrenia , 1996, Neuropsychopharmacology.

[37]  S. Potkin,et al.  Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[38]  J. Olney,et al.  Glutamate receptor dysfunction and schizophrenia. , 1995, Archives of general psychiatry.

[39]  S. Akbarian,et al.  GABAA receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls. , 1995, Cerebral cortex.

[40]  J. Ott,et al.  Schizophrenia: a genome scan targets chromosomes 3p and 8p as potential sites of susceptibility genes. , 1995, American journal of medical genetics.

[41]  H. Braak,et al.  Demonstration of Amyloid Deposits and Neurofibrillary Changes in Whole Brain Sections , 1991, Brain pathology.

[42]  S. Purcell,et al.  Support for involvement of neuregulin 1 in schizophrenia pathophysiology , 2005, Molecular Psychiatry.

[43]  H. Möller,et al.  World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Acute treatment of schizophrenia , 2005, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[44]  H. Beckmann,et al.  Prenatal developmental disturbances in the limbic allocortex in schizophrenics , 2005, Journal of Neural Transmission.

[45]  Paul J. Harrison,et al.  Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence , 2005, Molecular Psychiatry.

[46]  H. Stefánsson,et al.  Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. , 2003, American journal of human genetics.

[47]  Hongyan Zhang,et al.  Association study of neuregulin 1 gene with schizophrenia , 2003, Molecular Psychiatry.

[48]  P. Goldman-Rakic,et al.  Functional and anatomical aspects of prefrontal pathology in schizophrenia. , 1997, Schizophrenia bulletin.

[49]  M. Ozaki,et al.  Neuregulin-beta induces expression of an NMDA-receptor subunit. , 1997, Nature.